Alex Thurman
Director Financiero/CFO en GLAUKOS CORPORATION .
Fortuna: 5 M $ al 30/04/2024
Cargos activos de Alex Thurman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GLAUKOS CORPORATION | Director Financiero/CFO | 01/04/2022 | - |
Director Administrativo | 01/07/2016 | 01/12/2016 | |
Comptroller/Controller/Auditor | 01/07/2016 | 01/12/2016 | |
Corporate Officer/Principal | 01/12/2016 | 01/04/2022 | |
ALLERGAN PLC | Director Financiero/CFO | 01/12/2016 | - |
Historial de carrera de Alex Thurman
Formación de Alex Thurman.
Brigham Young University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Irlanda | 2 |
Operativa
Director of Finance/CFO | 2 |
Chief Administrative Officer | 1 |
Comptroller/Controller/Auditor | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GLAUKOS CORPORATION | Health Technology |
Empresas privadas | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Alex Thurman
- Experiencia